Skip to main content
HHS Author Manuscripts logoLink to HHS Author Manuscripts
. Author manuscript; available in PMC: 2015 Nov 2.
Published in final edited form as: Int J Infect Dis. 2012 Aug 29;16(12):e866–e871. doi: 10.1016/j.ijid.2012.07.016

Bronchiolitis outbreak caused by respiratory syncytial virus in southwest Bangladesh, 2010

Farhana Haque a,b,*, M Mushtuq Husain b, Kazi Mohammad Hassan Ameen b, Refat Rahima b, M Jahangir Hossain a, ASM Alamgir b, Mustafizur Rahman a, Mahmudur Rahman b, Stephen P Luby a,c
PMCID: PMC4629474  NIHMSID: NIHMS732118  PMID: 22938872

SUMMARY

Background

During July 2010, newspapers reported a respiratory disease outbreak in southwestern Bangladesh resulting in the admission of children to a secondary care hospital. We investigated this outbreak to determine the etiology and explore possible risk factors.

Methods

The hospital’s physician diagnosed children aged <2 years with cough, tachypnea or dyspnea, and expiratory wheeze as having acute bronchiolitis. We reviewed the hospital records and listed case patients admitted between 26 June and 26 July 2010. We surveyed the case patients and collected nasal and throat swabs to test for respiratory viruses.

Results

We identified 101 admitted acute bronchiolitis case patients. Fifty-nine (58%) of these were admitted between 16 and 20 July. Among the 29 case patients surveyed, the median age was 4 months and 65% were males. We identified respiratory syncytial virus (RSV) in 91% (21/23) of the samples, 43% of which had a dual viral infection. Most case patients (90%) were treated with broad-spectrum antibiotics. There were no reported deaths.

Conclusions

The sudden increase in admitted acute bronchiolitis case patients, their median age, and identification of RSV in the majority of samples suggest an outbreak of RSV bronchiolitis. Research to identify strategies to prevent respiratory infections including RSV in low-income settings should be prioritized. Factors that perpetuate antibiotic use in managing this viral syndrome should also be explored.

Keywords: Bronchiolitis, Outbreak, Respiratory syncytial virus, RSV, Bangladesh

1. Introduction

Respiratory syncytial virus (RSV) is recognized globally as the leading cause of acute bronchiolitis both in epidemics and sporadic cases.13 Although disease burden data from low-income countries are limited, extrapolation using data from high-income countries suggests an estimated annual global RSV burden of approximately 64 million cases with 160 000 annual deaths.46 It is estimated that 2–3% of all children aged <1 year require hospitalization during seasonal RSV epidemics.3,6

Acute bronchiolitis is a potentially life-threatening lower respiratory tract infection in infants that results from inflammatory obstruction of the small airways.1,3 Although bronchiolitis is common and most infants recover, the lack of a standard case definition,7 little knowledge about what makes infants particularly vulnerable to RSV, and no recommended specific therapy, all make bronchiolitis prevention and management difficult for clinicians, researchers, and public health professionals.3 Adding to the clinical perplexity, the data on disease burden, epidemiology, seasonality, risk factors, and clinical profiles of bronchiolitis are limited in the majority of resource-limited settings, including Bangladesh.

The Institute of Epidemiology, Disease Control and Research (IEDCR), the Government of Bangladesh’s institute responsible for outbreak investigations and disease surveillance, contracts a media agency to scan reports from 10 national newspapers and six popular local television channels on a daily basis and forward reports of potential outbreaks to IEDCR authorities. Several newspapers first reported an outbreak of a pneumonia-like illness that affected “hundreds of children” <2 years of age who were seeking admission to a government secondary care hospital in Meherpur District in southwestern Bangladesh during July 17–18, 2010. Within the disease surveillance team, these media reports raised the possibility of the emergence of a new respiratory pathogen of public health importance, and so a collaborative team from IEDCR and the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) investigated this outbreak during July 2010. This paper summarizes the results of the outbreak investigation, which aimed to determine the etiology of illness, explore possible exposures, and describe the clinical profiles of case patients to recommend possible control and prevention measures.

2. Methods

2.1. Outbreak verification, case detection, and descriptive investigation

To collect preliminary information and verify the occurrence of the outbreak that was reported in the newspapers, the outbreak investigation team contacted the Civil Surgeon of Meherpur District and the Upazila Health and Family Planning Officers of Gangni and Mujibnagar subdistricts (upazilas). From 24 to 26 July 2010, the team visited Meherpur General Hospital and collected information on patient demographics (age, gender, and address), dates of admission and discharge, and the diagnoses from the hospital’s registry. In order to simplify case management of childhood illnesses including acute respiratory infections (ARI) and diarrheal diseases at the primary health care settings, the Government of Bangladesh introduced the Integrated Management of Childhood Illnesses (IMCI) strategy nationwide in 2002. According to this IMCI guideline, any child aged <5 years presenting with cough and fast breathing and/or difficult breathing for less than 30 days and with any general danger sign (unable to drink or breast feed, vomits everything, convulsions, lethargy, grunting, fever of 37.5 °C or above or feels hot, low body temperature of less than 35.5 °C or feels cold, movement only when stimulated, no movement at all, unconsciousness), or chest indrawing or stridor in a calm child, was categorized as a case of ARI.8 We assumed that the hospital physicians used this IMCI case definition during admissions to classify patients presenting with respiratory symptoms under the broad category of ARI. Following admission, the single pediatrician at the hospital re-assessed all admitted ARI patients and diagnosed children aged <2 years who initially developed coryza and/or low-grade fever followed by cough, fast breathing (tachypnea) or shortness of breath (dyspnea), and expiratory wheeze8,9 as acute bronchiolitis. From the hospital’s registry, we listed all children aged <5 years who were admitted with ARI between 26 June and 26 July 2010. We also listed the patients diagnosed as cases of acute bronchiolitis between 26 June and 26 July 2010 and sought hospital records to note their clinical prognosis. We chose the 30-day time period to permit comparison of the monthly admission rates for acute bronchiolitis with previous months. We requested the Civil Surgeon to review the hospital records and then report to IEDCR the total number of patients discharged with a diagnosis of acute bronchiolitis who were classified using the same criteria by the pediatrician in the Meherpur General Hospital from January to December 2010.

To describe the outbreak in terms of persons, the team surveyed the case patients who were still in the hospital during the period of the investigation. We selected the mother as the primary survey respondent to provide information regarding her child’s health. If the mother was unavailable, we interviewed other family members. We explored clinical histories of these case patients, including exposure to possible risk factors, using a pretested, structured questionnaire that was jointly developed by IEDCR and ICDDR,B for investigating respiratory disease outbreaks. Physicians on the outbreak investigation team physically examined the hospitalized case patients looking for symptoms and signs of illness severity including central (bluish tongue) and peripheral cyanosis (bluish limbs).1012 The team recorded both the clinical features they observed and those reported in the patient information sheet by the attending physician during admission. We reviewed the patient treatment records to gather information regarding clinical management.

To determine if the acute bronchiolitis case patients surveyed in the hospital were similar to or different from those already discharged prior to the investigation and to identify possible clusters, we segregated the 101 cases in the line-list (identified from the hospital’s registry) based on the villages where they lived. The team defined a cluster of bronchiolitis if at least three admitted bronchiolitis cases came from the same village and lived within 15 min walking distance from each other according to the local community health worker. The team visited village communities with suspected clusters to survey and physically examine selected acute bronchiolitis cases who had been discharged from the hospital after June 26 until the beginning of the investigation. The team collected information on demographic and clinical profiles and exposures of these bronchiolitis cases from their mothers (or family members if the mother was not available) using the same questionnaire that was used for the hospital survey. Team members also visited the three government-run primary care hospitals of the district to seek additional cases of acute bronchiolitis in admitted children aged <2 years.

2.2. Laboratory investigations

The investigation team collected nasal and throat swabs from all bronchiolitis case patients surveyed in the hospital and from those discharged case patients who were still symptomatic during the cluster investigation. Following collection, both samples obtained from the same patient were immediately placed in a single vial with viral transport medium containing DMEM (Dullbecco’s modified Eagle’s medium), 2.5% BSA (bovine serum albumin) fraction V, 1% glutamine, 2% HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 1% penicillin–streptomycin, and Fungizone (250 mg/ml). The specimens were stored at 4–8 °C until transported within 72 h to IEDCR. The specimens were aliquoted in a biosafety level 2 safety cabinet and were stored in freezers at or below −70 °C until testing. At the Virology Laboratory of IEDCR, we performed RNA extraction and detected subtypes of influenza A and influenza B using a real-time reverse transcriptase polymerase chain reaction (rRT-PCR).13 Both RNA and DNA extraction were performed in a separate aliquot sent to the Virology Laboratory of ICDDR,B for molecular identification of other common respiratory viruses and bacteria. A real-time PCR respiratory pathogen panel assay developed by the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA, was used to detect respiratory pathogens including RSV, human parainfluenza virus 1, 2, and 3 (HPIV1, HPIV2, and HPIV3), human metapneumovirus (HMPV), adenovirus, Chlamydia pneumoniae, Mycoplasma pneumoniae, Streptococcus pneumoniae, Legionella pneumophila, and Legionella longbeachae.

2.3. Ethical considerations

We sought verbal informed consent from a parent of all participants. We suggested simple preventive measures including hand washing, and social distancing measures including cancellation of sports events to protect the wider community of the cluster villages. We also advised that parents avoid taking their ill child to public gatherings including mosques, weddings, and schools. This investigation was conducted in response to an outbreak and was approved by the Government of the People’s Republic of Bangladesh, but because this was an emergency response the activity was not reviewed by an independent human subjects committee.

3. Results

3.1. Spatial distribution, demographic, and clinical profiles of case patients

Acute bronchiolitis cases were admitted to Meherpur General Hospital throughout the year. However, monthly acute bronchiolitis admissions increased between June and October, with the highest number of admissions occurring during July 2010 (Figure 1). We identified 101 children who were hospitalized and diagnosed with acute bronchiolitis between 26 June and 26 July 2010. Compared to the previous month, acute bronchiolitis admissions increased by more than 60% during the month of July 2010 (Figure 1), with more than half of these cases (59/101) admitted between 16 and 20 July 2010 (Figure 2). Of the 258 children hospitalized with acute respiratory infections (ARIs) during this month, 101 (39%) had a discharge diagnosis of acute bronchiolitis. All except nine cases lived in different communities within the three subdistricts of Meherpur (Figure 3). Fifty-six percent (57/101) of the cases lived in the urban subdistrict, while the rest lived in the two other rural subdistricts (Mujibnagar and Gangni). We surveyed 20 case patients admitted to Meherpur General Hospital and nine from the two villages where we had identified clusters. The mean age of the 29 case patients was 5.4 months (median 4 months); 65% (19/29) were males and the average monthly household income was US$ 53 (range US$ 22–124).

Figure 1.

Figure 1

Total monthly acute bronchiolitis admissions in the Meherpur General Hospital, Bangladesh during 2010.

Figure 2.

Figure 2

Daily acute bronchiolitis admissions in the Meherpur General Hospital, Bangladesh during July 2010.

Figure 3.

Figure 3

Map showing the approximate location of the general (district) hospital and the three RSV outbreak affected upazilas of Meherpur District.

The main clinical symptoms included cough, fast breathing, shortness of breath, and feeding difficulty. About a quarter (7/29) reported a family history of atopy (defined as having asthma, eczema, or allergic rhinitis in the parents, or siblings or grandparents); 17% (5/29) of case patients had been affected at least once before with a similar illness that required hospitalization and 35% (10/29) were born prematurely. Thirty-one percent of respondents also reported that either another sibling or an extended family member had developed similar symptoms (cough/fast breathing/respiratory difficulty with a preceding mild fever/runny nose) within 1 week following the onset of illness in the child affected with bronchiolitis. All case patients were treated with supplemental oxygen, oral or inhalational bronchodilators, and nasal decongestants. Among the chest radiographs from nine case patients, the hospital’s pediatrician found patchy opacities or radiological evidence of bacterial pneumonia in only one case patient. Ninety percent (26/29) of the case patients received at least one broad-spectrum injectable antibiotic. There were no reported deaths from bronchiolitis or its complications among the 29 case patients (Table 1). As the hospital’s registry did not record patient outcome, we tried to assess the illness outcome of the remaining 72 cases by reviewing patient information sheets including copies of discharge and/or death certificates. We found that 75% (54/72) of the cases were discharged alive and 8% (6/72) were discharged against medical advice, a decision that families in low-income countries often make because of their inability to afford continued hospitalization, poor response to treatment, or dissatisfaction with the hospital environment.14 We could not retrieve the information sheets of 12 patients and the hospital records were insufficient to evaluate their outcomes.

Table 1.

Possible exposures, clinical presentation, management, and clinical outcome of case patients admitted with acute bronchiolitis in Meherpur General Hospital, July 24–26, 2010

Total number (%) (N = 29)
Risk factorsa
Passive smoking 8 (28)
Positive family history of atopy (asthma/allergic rhinitis/eczema) 7 (24)
Prematurity (reported by mothers as delivery before 9 completed months) 10 (35)
Twin/multiple birth 0 (0)
Exposure to multiple children (as in a health care setting/older siblings within the household) 6 (21)
Recommended feeding practices (exclusive breast feeding for <6 months/softened family foods in addition to breast milk for >6 months) 9 (31)
Past history of similar illness 5 (17)
Past history of similar illness requiring hospitalization 5 (17)
Close contact with any sick person 15 days prior to illness 9 (31)
Close contact with a sick family member 15 days prior to illness 4 (14)
Close contact with any extended family member ill with respiratory illness 15 days prior to illness 5 (17)
Any household member affected with similar illness 5 (17)
Any extended family member affected with similar illness 4 (14)
Clinical presentation
History of fever 16 (55)
Cough 26 (90)
Fast breathing (tachypnea) 26 (90)
Nasal congestion/coryza 13 (45)
Runny nose/clear rhinorrhea 21 (72)
Shortness of breath (dyspnea) 25 (86)
Feeding difficulty 17 (59)
Chest wall retraction (intercostals and/or subcostal recession) 11 (38)
Cyanosis 2 (7)
Loose motion 5 (17)
Clinical management
Oxygen therapy 23 (100)
Bronchodilators 23 (100)
Antibiotics 26 (90)
Nasal decongestants 23 (100)
Corticosteroids 5 (22)
Antiviral 0 (0)
Clinical outcomes or complications
Sepsis 0 (0)
Death 0 (0)
Recovery within 5 days 10 (36)
Still sick after 5 days of illness 11 (39)
a

Categories are not mutually exclusive.

3.2. Laboratory findings

Among the 29 acute bronchiolitis patients surveyed, we collected samples from 23 cases (including samples from all the 20 hospitalized cases and from three symptomatic discharged cases). Out of the 23 samples tested for different respiratory pathogens, 21 had detectable RNA for RSV, one had influenza A (H1N1), and one had influenza B. More than one virus was identified in 43% (9/21) of the RSV-positive cases. These co-infections included RSV with influenza A/H1N1 (n = 6), with influenza B (n = 1), and with adenovirus (n = 2) (Table 2). We did not detect any nucleic acids for bacterial pathogens in the specimens.

Table 2.

Summary of respiratory viruses detected in nasal and throat swabs collected from acute bronchiolitis cases admitted in the Meherpur General Hospital, July 2010

Virus types Total number of samples with detectable RNA for respiratory viruses (% of total samples) (N = 23)
RSV 21 (91)
 RSV alone 12 (52)
 RSV and influenza A (H1N1)pdm09 6 (26)
 RSV and adenovirus 2 (9)
 RSV and influenza B 1 (4)
Influenza A (H1N1)pdm09 only 1 (4)
Influenza B only 1 (4)
Human parainfluenza virus 0
Human metapneumovirus 0

RSV, respiratory syncytial virus.

4. Discussion

The sharp rise in the number of infant hospitalizations with a diagnosis of acute bronchiolitis heralded the occurrence of an outbreak in southwestern Bangladesh. We identified RSV in 91% of the samples tested from children hospitalized with acute bronchiolitis, which is comparable with findings from previous seasonal epidemics in other countries.1519 The median age of the affected children was 4 months, consistent with RSV bronchiolitis data from previous hospital-based studies.19,20 Seventeen percent of the case patients in our investigation had been hospitalized at least once before with similar symptoms within 1 year. Although RSV can re-infect, often with the same serotype, these prior admissions may also have been from other respiratory viruses including adenovirus, human metapneumovirus, and parainfluenza virus circulating earlier in the year.

Nine out of the 21 respiratory specimens with detectable RNA from RSV also had detectable RNA from at least one other viral respiratory pathogen. This result supports previous studies, which have found a strong association between dual viral infections and severe bronchiolitis requiring hospitalization.21 In many communities the RSV epidemic period overlaps with human metapneumovirus (HMPV) seasonal epidemics, and co-infection with RSV and HMPV has been commonly reported in previous investigations.2224 However, our investigation found co-infections of RSV with H1N1, adenovirus, and influenza B virus. A previous study from Bangladesh that detected HMPV circulation during January through the end of June also detected co-infection of HMPV with influenza A virus but not RSV.22 This investigation carried out at the end of July was apparently conducted during a time when HMPV was not circulating.

Acute bronchiolitis, most likely caused by RSV, was responsible for more than a third of ARI admissions to Meherpur General Hospital during July 2010. This finding is comparable to previous studies conducted in low-income countries that have identified RSV in 15–40% of hospital admissions for pneumonia or bronchiolitis.25,26 We found no deaths among the cases that we investigated. A previous study on children hospitalized with a diagnosis of bronchiolitis in Bangladesh found a mortality rate of 2%.27 As we could not follow up all 101 cases in this investigation, we may have underestimated the mortality among hospitalized cases. It is also possible that the case definition we used did not identify those infants aged <2 months who were at higher risk of mortality from RSV bronchiolitis,12 as irritability, feeding difficulty, and breathing difficulty are often the only symptoms in this age group.28 Indeed, since in approximately a third of these investigated outbreak case patients other siblings or older family members also developed similar symptoms within 1 week, this suggests that the total community burden of RSV was greater than only those children hospitalized. Since we surveyed only 29 out of 101 cases over a few days and because various respiratory pathogens other than RSV could lead to similar symptoms, it is possible that the findings of the survey cases may be different from all outbreak-associated cases. However, the epidemiological and the laboratory findings of the nine cases surveyed in the cluster investigation to trace back discharged cases were comparable to the findings of the 20 cases surveyed in the hospital, suggesting that the 29 surveyed patients were representative of the larger affected population.

Despite evidence from developed nations suggesting a very low risk of secondary bacterial infection following RSV bronchiolitis29 and Bangladesh’s national bronchiolitis guidelines restricting antibiotic use only to severe cases with laboratory and/or radiological evidence of bacterial pneumonia,30 antibiotics were administered to 90% of the case patients. Undue use of antibiotics, variation in clinical care, and poor adherence to national guidelines in the management of acute bronchiolitis have been reported previously.12,31 Evidence from controlled trials, including one multicenter randomized controlled trial that was conducted in five tertiary care hospitals of Bangladesh, showed that antibiotics were not effective in the management of bronchiolitis in low-income countries with a high ARI burden.32,33 Further research within Bangladesh could determine if this non-compliance to clinical guidelines with regard to avoiding antibiotics in acute bronchiolitis results from structural issues, including a lack of diagnostic facilities, or from attitudinal factors that consider antibiotics an essential therapy for infectious disease management.

In a country where approximately 70% of the health care expenditure is out-of-pocket for patients, the economic burden associated with the hospital-based management of RSV bronchiolitis, particularly the cost associated with injectable antibiotic therapy, can be catastrophic to the affected household.34 Specific diagnostic tests, such as PCR for the detection of RSV in the hospital, have led to the reduced prescription of antibiotics in the management of bronchiolitis in the USA.31 The introduction of affordable rapid diagnostic tests in the hospital setting for the service users, including antigen detection tests with an overall sensitivity of 80–90%,7 could decrease the indiscriminate use of antibiotics and also reduce financial loss. However, the practical applicability and cost-effectiveness of introducing advanced diagnostic techniques should be evaluated in the Bangladeshi context.

We identified this outbreak of RSV from newspaper reports. Even though what we identified was not a novel respiratory pathogen, following up on mass media reports of outbreaks might be a valuable strategy to identify events of public health concern. RSV, the leading cause of potentially life-threatening viral respiratory tract infection in infants,4,5,35,36 likely contributes significantly to childhood morbidity and mortality in low-income settings.37 Given the paucity of public health interventions to prevent respiratory infections including RSV in low-income settings, further research for identifying preventive strategies including improvement of hand hygiene practices and cough etiquette employed in developed nations38,39 should be prioritized.

Acknowledgments

The authors would like to thank all the study participants for their contributions. We are also grateful to the Civil Surgeon of Meherpur District and the Upazila Health and Family Planning Officers of Gangni and Mujibnagar Upazilas. Dorothy Southern, Emily S. Gurley, and Katharine Sturm-Ramirez deserve special thanks for their contributions in reviewing the manuscript.

Funding: This investigation was funded by the Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA and the Government of the People’s Republic of Bangladesh. ICDDR,B acknowledges with gratitude the commitment of the Government of Bangladesh and the CDC to its research efforts.

Footnotes

Presented as an abstract at the International Conference on Emerging Infectious Diseases, Atlanta, Georgia, USA, March 11–14, 2012.

Ethical approval: Ethical approval was not required for this investigation. This investigation was conducted in response to an outbreak and was approved by the Government of the People’s Republic of Bangladesh, but because this was an emergency response the activity was not reviewed by an independent human subjects committee. However, verbal informed consent was sought from parents of all participants.

Conflict of interest: The authors do not have any commercial or other association that might pose a conflict of interest.

References

  • 1.Goodman D. Inflammatory disorders of the small airways—bronchiolitis. 17. Pennsylvania: Saunders; 2004. [Google Scholar]
  • 2.Scheld WM, Craig WA, Hughes JM. Emerging infections. Washington DC: ASM Press; 2000. [Google Scholar]
  • 3.Smyth RL, Openshaw PJ. Bronchiolitis. Lancet. 2006;368:312–22. doi: 10.1016/S0140-6736(06)69077-6. [DOI] [PubMed] [Google Scholar]
  • 4.Cherian T, Simoes EA, Steinhoff MC, Chitra K, John M, Raghupathy P, John TJ. Bronchiolitis in tropical south India. Am J Dis Child. 1990;144:1026–30. doi: 10.1001/archpedi.1990.02150330086028. [DOI] [PubMed] [Google Scholar]
  • 5.Tariq WU, Waqar T, Ali S, Ghani E. Winter peak of respiratory syncytial virus in Islamabad. Trop Doct. 2005;35:28–9. doi: 10.1258/0049475053001958. [DOI] [PubMed] [Google Scholar]
  • 6.World Health Organization. Acute respiratory infections. Geneva: WHO; 2010. [Google Scholar]
  • 7.Bordley WC, Viswanathan M, King VJ, Sutton SF, Jackman AM, Sterling L, Lohr KN. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med. 2004;158:119–26. doi: 10.1001/archpedi.158.2.119. [DOI] [PubMed] [Google Scholar]
  • 8.World Health Organization. Handbook IMCI: integrated management of childhood illnesses. Dhaka: Government of the People’s Republic of Bangladesh; 2008. [Google Scholar]
  • 9.Molla MR. Concise textbook of pediatrics. 2. Dhaka: Quamrun Nahar Begum Daisy; 2003. [Google Scholar]
  • 10.Mai T, Selby A, Simpson J, Isaacs D. Use of simple clinical parameters to assess severity of bronchiolitis. J Paediatr Child Health. 1995;31:465–8. doi: 10.1111/j.1440-1754.1995.tb00859.x. [DOI] [PubMed] [Google Scholar]
  • 11.Mulholland EK, Olinsky A, Shann FA. Clinical findings and severity of acute bronchiolitis. Lancet. 1990;335:1259–61. doi: 10.1016/0140-6736(90)91314-z. [DOI] [PubMed] [Google Scholar]
  • 12.Al-Muhsen SZ. Clinical profile of respiratory syncytial virus (RSV) bronchiolitis in the intensive care unit at a tertiary care hospital. Curr Pediatr Res. 2010;14:75–80. [Google Scholar]
  • 13.Centers for Disease Control and Prevention. Protocol of realtime RTPCR for influenza A (H1N1) Atlanta, GA: CDC; 2009. [Google Scholar]
  • 14.Eze B, Agu K, Nwosu J. Discharge against medical advice at a tertiary center in southeastern Nigeria: sociodemographic and clinical dimensions. Patient Intelligence. 2010;2:27–31. [Google Scholar]
  • 15.Bakir TM, Halawani M, Ramia S. Viral aetiology and epidemiology of acute respiratory infections in hospitalized Saudi children. J Trop Pediatr. 1998;44:100–3. doi: 10.1093/tropej/44.2.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Berman S, Duenas A, Bedoya A, Constain V, Leon S, Borrero I, Murphy J. Acute lower respiratory tract illnesses in Cali, Colombia: a two-year ambulatory study. Pediatrics. 1983;71:210–8. [PubMed] [Google Scholar]
  • 17.Henderson J, Hilliard TN, Sherriff A, Stalker D, Al Shammari N, Thomas HM. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol. 2005;16:386–92. doi: 10.1111/j.1399-3038.2005.00298.x. [DOI] [PubMed] [Google Scholar]
  • 18.Henrickson KJ, Hoover S, Kehl KS, Hua W. National disease burden of respiratory viruses detected in children by polymerase chain reaction. Pediatr Infect Dis J. 2004;23:S11–8. doi: 10.1097/01.inf.0000108188.37237.48. [DOI] [PubMed] [Google Scholar]
  • 19.Sung RY, Chan RC, Tam JS, Cheng AF, Murray HG. Epidemiology and aetiology of acute bronchiolitis in Hong Kong infants. Epidemiol Infect. 1992;108:147–54. doi: 10.1017/s0950268800049591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med. 2004;350:443–50. doi: 10.1056/NEJMoa025472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C, et al. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J Infect Dis. 2005;191:382–6. doi: 10.1086/426457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Brooks WA, Erdman D, Terebuh P, Klimov A, Goswami D, Sharmeen AT, et al. Human metapneumovirus infection among children, Bangladesh. Emerg Infect Dis. 2007;13:1611–3. doi: 10.3201/eid1310.070337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Greensill J, McNamara PS, Dove W, Flanagan B, Smyth RL, Hart CA. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis. 2003;9:372–5. doi: 10.3201/eid0903.020289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mullins JA, Lamonte AC, Bresee JS, Anderson LJ. Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J. 2003;22:857–62. doi: 10.1097/01.inf.0000090921.21313.d3. [DOI] [PubMed] [Google Scholar]
  • 25.Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA. 1999;282:1440–6. doi: 10.1001/jama.282.15.1440. [DOI] [PubMed] [Google Scholar]
  • 26.Weber MW, Mulholland EK, Greenwood BM. Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health. 1998;3:268–80. doi: 10.1046/j.1365-3156.1998.00213.x. [DOI] [PubMed] [Google Scholar]
  • 27.Kabir ML, Haq N, Hoque M, Ahmed F, Amin R, Hossain A, et al. Evaluation of hospitalized infants and young children with bronchiolitis—a multi centre study. Mymensingh Med J. 2003;12:128–33. [PubMed] [Google Scholar]
  • 28.Centers for Disease Control Prevention. Respiratory syncytial virus. Atlanta, GA: CDC; 2010. RSV Factsheet. [Google Scholar]
  • 29.Bloomfield P, Dalton D, Karleka A, Kesson A, Duncan G, Isaacs D. Bacteraemia and antibiotic use in respiratory syncytial virus infections. Arch Dis Child. 2004;89:363–7. doi: 10.1136/adc.2003.035105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.National guidelines: asthma, bronchiolitis, COPD. Dhaka: Asthma Association Bangladesh; 2005. [Google Scholar]
  • 31.Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatient diagnostic testing and management of bronchiolitis. Pediatrics. 2005;115:878–84. doi: 10.1542/peds.2004-1299. [DOI] [PubMed] [Google Scholar]
  • 32.Field CM, Connolly JH, Murtagh G, Slattery CM, Turkington EE. Antibiotic treatment of epidemic bronchiolitis—a double-blind trial. Br Med J. 1966;1:83–5. doi: 10.1136/bmj.1.5479.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Spurling GK, Fonseka K, Doust J, Del Mar C. Antibiotics for bronchiolitis in children. Cochrane Database Syst Rev. 2007;(1):CD005189. doi: 10.1002/14651858.CD005189.pub2. [DOI] [PubMed] [Google Scholar]
  • 34.Alamgir NI, Naheed A, Luby SP. Coping strategies for financial burdens in families with childhood pneumonia in Bangladesh. BMC Public Health. 2010;10:622. doi: 10.1186/1471-2458-10-622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hacking D, Hull J. Respiratory syncytial virus—viral biology and the host response. J Infect. 2002;45:18–24. doi: 10.1053/jinf.2002.1015. [DOI] [PubMed] [Google Scholar]
  • 36.Jeng MJ, Lemen RJ. Respiratory syncytial virus bronchiolitis. Am Fam Physician. 1997;55:1139–46–1149–50. [PubMed] [Google Scholar]
  • 37.Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55. doi: 10.1016/S0140-6736(10)60206-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.HPA. Respiratory Syncytial Virus (RSV) UK: Health Protection Agency; 2010. [Google Scholar]
  • 39.Jefferson T, Del Mar C, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ. 2009;339:b3675. doi: 10.1136/bmj.b3675. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES